Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Clay

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Bioorganic & Medicinal Chemistry|January 20, 2007
Azetidinones as vasopressin V1a antagonistsChristophe D Guillon, Gary A Koppel, Michael J Brownstein, et al.
Journal of Medicinal Chemistry|August 5, 2005
Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonistAna Belén Bueno, Iván Collado, Alfonso de Dios, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Plos One|March 30, 2012
Protecting important sites for biodiversity contributes to meeting global conservation targetsStuart H M Butchart, Jörn P W Scharlemann, Mike I Evans, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Bioorganic & Medicinal Chemistry|January 20, 2007
Azetidinones as vasopressin V1a antagonistsChristophe D Guillon, Gary A Koppel, Michael J Brownstein, et al.
Journal of Medicinal Chemistry|August 5, 2005
Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonistAna Belén Bueno, Iván Collado, Alfonso de Dios, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Plos One|March 30, 2012
Protecting important sites for biodiversity contributes to meeting global conservation targetsStuart H M Butchart, Jörn P W Scharlemann, Mike I Evans, et al.
Pageof 9